UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest event Reported): January 30, 2017
DNA TESTING CENTERS, CORP.
(Exact name of registrant as specified in its charter)
Florida | 333-199589 | N/A |
(State or other jurisdiction of | (Commission File Number) | (IRS Employer Identification No.) |
incorporation or organization) |
|
|
|
|
|
2378 Parkhaven Blvd., Oakville, ON, L6H 0E7, Canada | ||
(Address of principal executive offices) | ||
| ||
(866) 863-5139 | ||
(Registrant's telephone number, including area code) | ||
N/A | ||
(Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
Item 4.01 | Changes in Registrant’s Certifying Accountant |
(a) Previous independent registered public accounting firm
(i) | On January 30, 2017, DNA Testing Centers, Corp. (the “Company”) formally informed Malone |
(ii) | The reports of Malone |
(iii) | The Company’s Board of Directors participated in and approved the decision to change independent registered public accounting firms. |
(iv) | During the fiscal years ended December 31, 201 5 |
(v) | The Company has requested that Malone |
|
|
(b) New independent registered public accounting firm
| (1) | On January 30, 2017, the Company engaged Saturna Group Chartered Professional Accountants LLP ("Saturna Group LLP") as its new independent registered public accounting firm. During the two most recent fiscal years and through January 30, 2017, the Company had not consulted with Saturna Group LLP regarding any of the following: |
| (i) | The application of accounting principles to a specific transaction, either completed or proposed; |
| (ii) | The type of audit opinion that might be rendered on the Company’s financial statements, and none of the following was provided to the Company: (a) a written report, or (b) oral advice that Saturna Group LLP. concluded was an important factor considered by the Company in reaching a decision as to accounting, auditing or financial reporting issue; or |
| (iii) | Any matter that was subject of a disagreement, as that term is defined in Item 304(a)(1)(iv) of Regulation S-K. |
|
|
|
Item 9.01 | Financial Statements and Exhibits |
16.1 | Letter from Malone |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: February 3 , 2017
| DNA TESTING CENTERS, CORP. | ||
|
| ||
|
| ||
| By: | /s/ Barjinder Sohal | |
| Dr. Barjinder Sohal | ||
| Chief Executive Officer, President and Director | ||
|
| ||
|
|
|
|
3